23 publications
Name | Date | Type | Actions |
---|---|---|---|
Monthly information regarding the total number of voting rights and shares making of the share capital - December 2014 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
12/01/2015 | Voting rights | |
2014 sales up 5.2% to €315.3 million The Vétoquinol Group posted 2014 sales of €315.3 million, up 5.2% from the previous year. At constant exchange rates, sales rose by 6.3%. The Vétoquinol Group achieved organic growth of 1.4% in 2014. |
22/01/2015 | Public releases | |
Vétoquinol and Orion Pharma Animal Health enter into distribution collaboration Vétoquinol and Orion Pharma Animal Health - a part of Orion Corporation - announce their collaboration regarding the distribution of Dexdomitor®, Antisedan®, Domitor® and Domosedan®. Vétoquinol becomes distributor in selected European countries of these Orion Sedative products. |
05/02/2015 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - January 2015 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
06/02/2015 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - February 2015 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
12/03/2015 | Voting rights | |
Reference products up +13.2%. net income up +9.3% Lure, March 23, 2015 – At its meeting on March 17, 2015, the Vétoquinol S.A. Board of Directors reviewed the Group results and approved the 2014 financial statements. |
23/03/2015 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - March 2015 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
13/04/2015 | Voting rights | |
Q1 2015 sales show solid growth at €81.3 million (up +11.0%) Vétoquinol posted first quarter 2015 sales of €81.3 million (after currency gains of €4.5 million), up +11.0%. At constant exchange rates, first quarter 2015 sales amounted to €76.7 million, a +4.8% increase from €73.2 million in Q1 2014. |
14/04/2015 | Public releases | |
Vetoquinol publishes its registration document and its annual financial report relative to fiscal year 2015 (french version) The registration document of Vétoquinol relative to fiscal year 2014, including the annual financial report relative to fiscal year 2014, was filed with the Autorité des marchés financiers (“the AMF”) on April 17, 2015. |
20/04/2015 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - April 2015 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
19/05/2015 | Voting rights |